Tag Archive for: personalized medicine

In its most basic form, market access means ensuring patients can physically get a product. Sounds simple, right?

Rohit Nambisan and Andreas Matern of Lokavant share insights on where they see AI in clinical research and personalized medicine development next year.

Whether you’re an oncologist directing cancer care, or a health creative communicating science, the most consequential decisions are always human. Tech brainpower can inform our choices, but it takes empathy and real-world understanding to figure out what works best. And the question of how health can maximize AI continues to stoke debate.

Next-gen biomanufacturers are particularly susceptible to the challenges inherent in manufacturing cell and gene therapies, risking getting derailed by unexpected costs for already-tight budgets.

Can recent breakthroughs in artificial intelligence (AI) accelerate the development of personalized medicine?

The aim of the Lupus Nexus is to transform lupus research and drug development through unprecedented information exchange capabilities. The platform will provide a collaborative solution that is inclusive of diverse patient populations disproportionally affected by lupus.

One of the tenets of “personalized medicine” is that medications will be tailored to individuals based on their personalized genetics. Last year, the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research approved 50 drugs. A new study found that 33, or 66% of them, were supported with genomic data.